 | • レポートコード：MRC2012A5868 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、メラノコルチン受容体4の世界市場を広く調査・分析し、今後の市場展望をまとめております。メラノコルチン受容体4の種類別市場規模（ブレメラノチド、コルチコトロピン、コシントロピン、その他）、用途別市場規模（代謝障害、女性健康、泌尿生殖器系、感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca Plc、Palatin Technologies, Inc.、Mallinckrodt Plc、Rhythm Pharmaceuticals, Inc.、Obexia AG、Retrophin Inc.、Pfizer Inc.、 ・地域別グローバル市場分析 2015年-2020年 ・メラノコルチン受容体4の北米市場（アメリカ、カナダ、メキシコ） ・メラノコルチン受容体4のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・メラノコルチン受容体4のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・メラノコルチン受容体4の南米市場（ブラジル、アルゼンチン） ・メラノコルチン受容体4の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ブレメラノチド、コルチコトロピン、コシントロピン、その他 ・用途別分析：代謝障害、女性健康、泌尿生殖器系、感染症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Melanocortin Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Melanocortin Receptor 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Melanocortin Receptor 4 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Melanocortin Receptor 4 market has been segmented into
Bremelanotide
Corticotropin
Cosyntropin
Others
By Application, Melanocortin Receptor 4 has been segmented into:
Metabolic Disorder
Women’s Health
Genito Urinary System
Infection Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Melanocortin Receptor 4 market presented in the report. This section sheds light on the sales growth of different regional and country-level Melanocortin Receptor 4 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Melanocortin Receptor 4 market.
The report offers in-depth assessment of the growth and other aspects of the Melanocortin Receptor 4 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Melanocortin Receptor 4 Market Share Analysis
Melanocortin Receptor 4 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Melanocortin Receptor 4 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Melanocortin Receptor 4 sales, revenue and market share for each player covered in this report.
The major players covered in Melanocortin Receptor 4 are:
AstraZeneca Plc
Palatin Technologies, Inc.
Mallinckrodt Plc
Rhythm Pharmaceuticals, Inc.
Obexia AG
Retrophin Inc.
Pfizer Inc.
Among other players domestic and global, Melanocortin Receptor 4 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Melanocortin Receptor 4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Melanocortin Receptor 4, with price, sales, revenue and global market share of Melanocortin Receptor 4 in 2018 and 2019.
Chapter 3, the Melanocortin Receptor 4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Melanocortin Receptor 4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Melanocortin Receptor 4 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Melanocortin Receptor 4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Melanocortin Receptor 4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Melanocortin Receptor 4 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Bremelanotide
1.2.3 Corticotropin
1.2.4 Cosyntropin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Melanocortin Receptor 4 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Metabolic Disorder
1.3.3 Women’s Health
1.3.4 Genito Urinary System
1.3.5 Infection Disease
1.3.6 Others
1.4 Overview of Global Melanocortin Receptor 4 Market
1.4.1 Global Melanocortin Receptor 4 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Palatin Technologies, Inc.
2.2.1 Palatin Technologies, Inc. Details
2.2.2 Palatin Technologies, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Palatin Technologies, Inc. SWOT Analysis
2.2.4 Palatin Technologies, Inc. Product and Services
2.2.5 Palatin Technologies, Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mallinckrodt Plc
2.3.1 Mallinckrodt Plc Details
2.3.2 Mallinckrodt Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mallinckrodt Plc SWOT Analysis
2.3.4 Mallinckrodt Plc Product and Services
2.3.5 Mallinckrodt Plc Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Rhythm Pharmaceuticals, Inc.
2.4.1 Rhythm Pharmaceuticals, Inc. Details
2.4.2 Rhythm Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Rhythm Pharmaceuticals, Inc. SWOT Analysis
2.4.4 Rhythm Pharmaceuticals, Inc. Product and Services
2.4.5 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Obexia AG
2.5.1 Obexia AG Details
2.5.2 Obexia AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Obexia AG SWOT Analysis
2.5.4 Obexia AG Product and Services
2.5.5 Obexia AG Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Retrophin Inc.
2.6.1 Retrophin Inc. Details
2.6.2 Retrophin Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Retrophin Inc. SWOT Analysis
2.6.4 Retrophin Inc. Product and Services
2.6.5 Retrophin Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer Inc.
2.7.1 Pfizer Inc. Details
2.7.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer Inc. SWOT Analysis
2.7.4 Pfizer Inc. Product and Services
2.7.5 Pfizer Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Melanocortin Receptor 4 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Melanocortin Receptor 4 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Melanocortin Receptor 4 Manufacturer Market Share in 2019
3.3.2 Top 6 Melanocortin Receptor 4 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Melanocortin Receptor 4 Sales, Revenue and Market Share by Regions
4.1.1 Global Melanocortin Receptor 4 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Melanocortin Receptor 4 Revenue and Market Share by Regions (2015-2020)
4.2 North America Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
4.3 Europe Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
4.5 South America Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Melanocortin Receptor 4 Sales, Revenue and Market Share by Country
5.1.1 North America Melanocortin Receptor 4 Sales and Market Share by Country (2015-2020)
5.1.2 North America Melanocortin Receptor 4 Revenue and Market Share by Country (2015-2020)
5.2 United States Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
5.3 Canada Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
5.4 Mexico Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Melanocortin Receptor 4 Sales, Revenue and Market Share by Country
6.1.1 Europe Melanocortin Receptor 4 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Melanocortin Receptor 4 Revenue and Market Share by Country (2015-2020)
6.2 Germany Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
6.3 UK Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
6.4 France Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
6.5 Russia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
6.6 Italy Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Melanocortin Receptor 4 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Melanocortin Receptor 4 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Melanocortin Receptor 4 Revenue and Market Share by Regions (2015-2020)
7.2 China Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7.3 Japan Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7.4 Korea Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7.5 India Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
7.7 Australia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Melanocortin Receptor 4 Sales, Revenue and Market Share by Country
8.1.1 South America Melanocortin Receptor 4 Sales and Market Share by Country (2015-2020)
8.1.2 South America Melanocortin Receptor 4 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
8.3 Argentina Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Melanocortin Receptor 4 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Melanocortin Receptor 4 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Melanocortin Receptor 4 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
9.3 Turkey Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
9.4 Egypt Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
9.5 South Africa Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Melanocortin Receptor 4 Sales and Market Share by Type (2015-2020)
10.2 Global Melanocortin Receptor 4 Revenue and Market Share by Type (2015-2020)
10.3 Global Melanocortin Receptor 4 Price by Type (2015-2020)
11 Global Melanocortin Receptor 4 Market Segment by Application
11.1 Global Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
11.2 Global Melanocortin Receptor 4 Revenue Market Share by Application (2015-2020)
11.3 Global Melanocortin Receptor 4 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Melanocortin Receptor 4 Sales, Revenue and Growth Rate (2021-2025)
12.2 Melanocortin Receptor 4 Market Forecast by Regions (2021-2025)
12.2.1 North America Melanocortin Receptor 4 Market Forecast (2021-2025)
12.2.2 Europe Melanocortin Receptor 4 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Melanocortin Receptor 4 Market Forecast (2021-2025)
12.2.4 South America Melanocortin Receptor 4 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Melanocortin Receptor 4 Market Forecast (2021-2025)
12.3 Melanocortin Receptor 4 Market Forecast by Type (2021-2025)
12.3.1 Global Melanocortin Receptor 4 Sales Forecast by Type (2021-2025)
12.3.2 Global Melanocortin Receptor 4 Market Share Forecast by Type (2021-2025)
12.4 Melanocortin Receptor 4 Market Forecast by Application (2021-2025)
12.4.1 Global Melanocortin Receptor 4 Sales Forecast by Application (2021-2025)
12.4.2 Global Melanocortin Receptor 4 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Melanocortin Receptor 4 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Melanocortin Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Melanocortin Receptor 4 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Melanocortin Receptor 4 Major Business
Table 9. AstraZeneca Plc Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc Melanocortin Receptor 4 Product and Services
Table 12. AstraZeneca Plc Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Palatin Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Palatin Technologies, Inc. Melanocortin Receptor 4 Major Business
Table 15. Palatin Technologies, Inc. Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 16. Palatin Technologies, Inc. SWOT Analysis
Table 17. Palatin Technologies, Inc. Melanocortin Receptor 4 Product and Services
Table 18. Palatin Technologies, Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mallinckrodt Plc Basic Information, Manufacturing Base and Competitors
Table 20. Mallinckrodt Plc Melanocortin Receptor 4 Major Business
Table 21. Mallinckrodt Plc Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 22. Mallinckrodt Plc SWOT Analysis
Table 23. Mallinckrodt Plc Melanocortin Receptor 4 Product and Services
Table 24. Mallinckrodt Plc Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Rhythm Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Major Business
Table 27. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 28. Rhythm Pharmaceuticals, Inc. SWOT Analysis
Table 29. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product and Services
Table 30. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Obexia AG Basic Information, Manufacturing Base and Competitors
Table 32. Obexia AG Melanocortin Receptor 4 Major Business
Table 33. Obexia AG Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 34. Obexia AG SWOT Analysis
Table 35. Obexia AG Melanocortin Receptor 4 Product and Services
Table 36. Obexia AG Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Retrophin Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Retrophin Inc. Melanocortin Receptor 4 Major Business
Table 39. Retrophin Inc. Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 40. Retrophin Inc. SWOT Analysis
Table 41. Retrophin Inc. Melanocortin Receptor 4 Product and Services
Table 42. Retrophin Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc. Melanocortin Receptor 4 Major Business
Table 45. Pfizer Inc. Melanocortin Receptor 4 Total Revenue (USD Million) (2017-2018)
Table 46. Pfizer Inc. SWOT Analysis
Table 47. Pfizer Inc. Melanocortin Receptor 4 Product and Services
Table 48. Pfizer Inc. Melanocortin Receptor 4 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Melanocortin Receptor 4 Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Melanocortin Receptor 4 Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Melanocortin Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Melanocortin Receptor 4 Sales Market Share by Regions (2015-2020)
Table 53. Global Melanocortin Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Melanocortin Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Melanocortin Receptor 4 Sales Market Share by Countries (2015-2020)
Table 56. North America Melanocortin Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 58. Europe Melanocortin Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Melanocortin Receptor 4 Sales Market Share by Countries (2015-2020)
Table 60. Europe Melanocortin Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Melanocortin Receptor 4 Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Melanocortin Receptor 4 Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Melanocortin Receptor 4 Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Melanocortin Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Melanocortin Receptor 4 Sales Market Share by Countries (2015-2020)
Table 66. South America Melanocortin Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Melanocortin Receptor 4 Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Melanocortin Receptor 4 Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Melanocortin Receptor 4 Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020)
Table 72. Global Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 73. Global Melanocortin Receptor 4 Sales Share by Type (2015-2020)
Table 74. Global Melanocortin Receptor 4 Revenue by Type (2015-2020) (USD Million)
Table 75. Global Melanocortin Receptor 4 Revenue Share by Type (2015-2020)
Table 76. Global Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 77. Global Melanocortin Receptor 4 Sales Share by Application (2015-2020)
Table 78. Global Melanocortin Receptor 4 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Melanocortin Receptor 4 Market Share Forecast by Regions (2021-2025)
Table 80. Global Melanocortin Receptor 4 Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Melanocortin Receptor 4 Market Share Forecast by Type (2021-2025)
Table 82. Global Melanocortin Receptor 4 Sales Forecast by Application (2021-2025)
Table 83. Global Melanocortin Receptor 4 Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Melanocortin Receptor 4 Picture
Figure 2. Global Sales Market Share of Melanocortin Receptor 4 by Type in 2019
Figure 3. Bremelanotide Picture
Figure 4. Corticotropin Picture
Figure 5. Cosyntropin Picture
Figure 6. Others Picture
Figure 7. Melanocortin Receptor 4 Sales Market Share by Application in 2018
Figure 8. Metabolic Disorder Picture
Figure 9. Women's Health Picture
Figure 10. Genito Urinary System Picture
Figure 11. Infection Disease Picture
Figure 12. Others Picture
Figure 13. Global Melanocortin Receptor 4 Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Melanocortin Receptor 4 Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Melanocortin Receptor 4 Sales Market Share by Manufacturer in 2019
Figure 34. Global Melanocortin Receptor 4 Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Melanocortin Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Melanocortin Receptor 4 Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Melanocortin Receptor 4 Revenue Market Share by Regions (2015-2020)
Figure 41. Global Melanocortin Receptor 4 Revenue Market Share by Regions in 2018
Figure 42. North America Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
Figure 43. Europe Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
Figure 45. South America Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Melanocortin Receptor 4 Sales and Growth Rate (2015-2020)
Figure 47. North America Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Melanocortin Receptor 4 Sales Market Share by Countries (2015-2020)
Figure 49. North America Melanocortin Receptor 4 Sales Market Share by Countries in 2018
Figure 50. North America Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Melanocortin Receptor 4 Revenue Market Share by Countries in 2018
Figure 52. United States Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Melanocortin Receptor 4 Revenue Market Share by Countries in 2019
Figure 58. Germany Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Melanocortin Receptor 4 Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Melanocortin Receptor 4 Revenue Market Share by Regions 2019
Figure 66. China Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Melanocortin Receptor 4 Sales Market Share by Countries in 2019
Figure 73. South America Melanocortin Receptor 4 Revenue Market Share by Countries in 2019
Figure 74. Brazil Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Melanocortin Receptor 4 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Melanocortin Receptor 4 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Melanocortin Receptor 4 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Melanocortin Receptor 4 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Melanocortin Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Melanocortin Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Melanocortin Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Melanocortin Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Melanocortin Receptor 4 Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
メラノコルチン受容体4の世界市場（～2026年） Market Analysis and Insights: Global Melanocortin Receptor 4 Market The global Melanocortin Receptor 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Melanocortin Receptor 4 Scope and Market Size Melanocortin Receptor…- 副腎皮質刺激ホルモン受容体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adrenocorticotropic Hormone Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Adrenoco…
- 副腎皮質刺激ホルモン受容体の世界市場（～2026年） Market Analysis and Insights: Global Adrenocorticotropic Hormone Receptor Market The global Adrenocorticotropic Hormone Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adrenocorticotropic Hormone Receptor Scop…
- レプチン受容体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Leptin Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Leptin Receptor market report…
- エストロゲン受容体ベータの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Estrogen Receptor Beta market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Estrogen Receptor Beta…